174 related articles for article (PubMed ID: 22481618)
1. The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
Takeba Y; Matsumoto N; Watanabe M; Takenoshita-Nakaya S; Ohta Y; Kumai T; Takagi M; Koizumi S; Asakura T; Otsubo T
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1545-55. PubMed ID: 22481618
[TBL] [Abstract][Full Text] [Related]
2. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
3. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
5. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK.
Relja B; Meder F; Wang M; Blaheta R; Henrich D; Marzi I; Lehnert M
Int J Oncol; 2011 Mar; 38(3):879-85. PubMed ID: 21206971
[TBL] [Abstract][Full Text] [Related]
7. Targeting ROCK1/2 blocks cell division and induces mitotic catastrophe in hepatocellular carcinoma.
Wu H; Chen Y; Li B; Li C; Guo J; You J; Hu X; Kuang D; Qi S; Liu P; Li L; Xu C
Biochem Pharmacol; 2021 Feb; 184():114353. PubMed ID: 33278350
[TBL] [Abstract][Full Text] [Related]
8. Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition.
Zhang JG; Zhang DD; Wu X; Wang YZ; Gu SY; Zhu GH; Li XY; Li Q; Liu GL
BMC Cancer; 2015 Oct; 15():814. PubMed ID: 26510899
[TBL] [Abstract][Full Text] [Related]
9. The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer.
Yang X; Di J; Zhang Y; Zhang S; Lu J; Liu J; Shi W
Biomed Pharmacother; 2012 Apr; 66(3):221-7. PubMed ID: 22425182
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
11. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
[TBL] [Abstract][Full Text] [Related]
12. Fasudil inhibits the proliferation and contractility and induces cell cycle arrest and apoptosis of human endometriotic stromal cells: a promising agent for the treatment of endometriosis.
Tsuno A; Nasu K; Kawano Y; Yuge A; Li H; Abe W; Narahara H
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1944-52. PubMed ID: 21917869
[TBL] [Abstract][Full Text] [Related]
13. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
Zhang L; Li Q; Liu Z; Liu W; Zhao M
Inflammation; 2018 Dec; 41(6):2171-2183. PubMed ID: 30088170
[TBL] [Abstract][Full Text] [Related]
14. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.
Fukushima M; Nakamuta M; Kohjima M; Kotoh K; Enjoji M; Kobayashi N; Nawata H
Liver Int; 2005 Aug; 25(4):829-38. PubMed ID: 15998434
[TBL] [Abstract][Full Text] [Related]
15. Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis.
Takeba Y; Kumai T; Matsumoto N; Nakaya S; Tsuzuki Y; Yanagida Y; Kobayashi S
J Pharmacol Sci; 2007 Jul; 104(3):232-42. PubMed ID: 17609585
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
[TBL] [Abstract][Full Text] [Related]
17. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.
Zhou H; Zhang KX; Li YJ; Guo BY; Wang M; Wang M
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):387-94. PubMed ID: 21457293
[TBL] [Abstract][Full Text] [Related]
18. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
19. Fasudil, a Rho-associated protein kinase inhibitor, attenuates retinal ischemia and reperfusion injury in rats.
Song H; Gao D
Int J Mol Med; 2011 Aug; 28(2):193-8. PubMed ID: 21455561
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo.
Zhao Y; Zhang Y; Vazirinejad Mehdiabad M; Zhou K; Chen Y; Li L; Guo J; Xu C
PLoS One; 2019; 14(10):e0223232. PubMed ID: 31581236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
